It also downregulates key extracellular matrix regulators, resulting in improved liver function and histopathology
There are a whole class of medications that are insulin sensitizers, so perhaps we can develop medications that will allow people to be sensitized to GLP-1s or find formulations of GLP-1, like the longer-acting versions, that avoid the GLP-1 resistance, Gloyn said
37: 135-141.[DOI] [44] Wang L, Zhang X, Xiong X et al
The method of embodiment 35, wherein the composition comprises from about 14 wt % to about 18 wt % poloxamer 407
The defendants produce internal documents, clinical trial data, safety reports, marketing materials, and communications about their GLP-1 drugs
Topline results from this study reported average HbA1c reductions of 1.7% to 2.0% at 40 weeks, a substantial improvement for individuals with T2D